Xichen Lin - 03 Jun 2024 Form 4 Insider Report for Structure Therapeutics Inc. (GPCR)

Reporting owner
Signature
/s/ Jun Yoon, Attorney-in-Fact
Issuer context
Transaction snapshot
SEC evidence
Form type
4
Filing time
05 Jun 2024, 19:38:50 UTC
Previous filing
20 Mar 2024
Next filing
03 Jul 2025
SEC filing
View on sec.gov

Key filing fact

Xichen Lin filed Form 4 for Structure Therapeutics Inc. (GPCR) on 05 Jun 2024.

Key facts

  • This page summarizes Xichen Lin's Form 4 filing for Structure Therapeutics Inc. (GPCR).
  • 6 reported transactions and 4 derivative rows are listed below.
  • Filing timestamp: 05 Jun 2024, 19:38.

Change

  • Previous filing in this sequence was filed on 20 Mar 2024.
  • Current net transaction value: -$1,645,463.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reported transactions

GPCR transaction

Ordinary Shares

Options Exercise

Transaction value
$36,108
Shares
+106,200
Change %
+124%
Price
$0.3400*
Shares after
191,907
Date
03 Jun 2024
Ownership
Direct
GPCR transaction

Ordinary Shares

Conversion of derivative security

Transaction value
$0
Shares
-106,200
Change %
-55%
Price
$0.000000
Shares after
85,707
Date
03 Jun 2024
Ownership
Direct
Footnotes
F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

GPCR transaction Derivative

Share Option (right to buy)

Options Exercise

Transaction value
$0
Shares
-106,200
Change %
-33%
Price
$0.000000
Shares after
213,800
Date
03 Jun 2024
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
106,200
Exercise price
$0.3400
Footnotes
F2, F3
GPCR transaction Derivative

American Depositary Shares

Conversion of derivative security

Transaction value
$0
Shares
+35,400
Change %
Price
$0.000000
Shares after
35,400
Date
03 Jun 2024
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
106,200
Exercise price
Footnotes
F4, F5
GPCR transaction Derivative

American Depositary Shares

Sale

Transaction value
$796,500
Shares
-17,700
Change %
-50%
Price
$45.00
Shares after
17,700
Date
03 Jun 2024
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
53,100
Exercise price
Footnotes
F4, F6
GPCR transaction Derivative

American Depositary Shares

Sale

Transaction value
$885,071
Shares
-17,700
Change %
-100%
Price
$50.00
Shares after
0
Date
03 Jun 2024
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
53,100
Exercise price
Footnotes
F4, F6, F7
* indicates a reported price that failed the local validity check.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The Ordinary Shares were converted into American Depositary Shares as reported in Table II above.
F2 1/4 of the shares vested one year after July 22, 2019 (the "Vesting Commencement Date"); the balance of the shares vested in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date.
F3 This reflects the number of Ordinary Shares remaining under the share option following the partial exercise of the share option for 106,200 Ordinary Shares.
F4 Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date.
F5 106,200 Ordinary Shares, which were acquired upon exercise of a share option, were converted into 35,400 American Depositary Shares.
F6 The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on December 28, 2023.
F7 The weighted average sale price for the transaction reported was $50.004, and the range of prices were between $50.00 and $50.16. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .